Adaptimmune Therapeutics (ADAP) Stock Chart & Stock Price History → You need to know these two things about AI stocks ASAP… (From InvestorPlace) (Ad) Free ADAP Stock Alerts $1.15 -0.04 (-3.36%) (As of 05/6/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Adaptimmune Therapeutics Stock Price Performance5 Day Performance-3.36%1 Month Performance-16.06%3 Month Performance-7.26%6 Month Performance+92.95%Year-To-Date Performance+45.02%1 Year Performance-17.86% Receive ADAP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. ADAP Stock Chart for Tuesday, May, 7, 2024 ADAP Chart by TradingView Adaptimmune Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/06/2024$1.19$1.15-3.36%$1.23$1.11839,356 shs$283.84 million05/03/2024$1.19$1.19$1.24$1.17850,344 shs$293.72 million05/02/2024$1.21$1.19-1.65%$1.25$1.17716,109 shs$293.72 million05/01/2024$1.19$1.21+1.68%$1.25$1.16911,190 shs$298.65 million04/30/2024$1.15$1.19+3.48%$1.23$1.15655,747 shs$293.72 million04/29/2024$1.08$1.15+6.98%$1.20$1.071.15 million shs$283.84 million Get the Latest News and Ratings for ADAP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/26/2024$1.06$1.08+1.42%$1.09$1.031.16 million shs$178.16 million04/25/2024$1.08$1.06-1.85%$1.10$1.04565,527 shs$1.05 billion04/24/2024$1.14$1.08-5.26%$1.15$1.07777,793 shs$1.07 billion04/23/2024$1.01$1.14+12.87%$1.16$1.011.13 million shs$1.13 billion04/22/2024$0.98$1.01+3.41%$1.08$0.95694,241 shs$1.00 billion04/19/2024$0.90$0.98+8.72%$1.08$0.921.48 million shs$971.05 million04/18/2024$0.99$0.90-8.98%$0.99$0.873.32 million shs$893.20 million04/17/2024$1.03$0.99-4.17%$1.05$0.931.22 million shs$981.29 million04/16/2024$1.05$1.03-1.90%$1.06$0.981.22 million shs$1.02 billion04/15/2024$1.16$1.05-9.48%$1.21$1.051.32 million shs$1.04 billion04/12/2024$1.29$1.16-10.08%$1.28$1.133.08 million shs$1.15 billion04/11/2024$1.27$1.29+1.57%$1.34$1.26877,248 shs$1.28 billion04/10/2024$1.37$1.27-7.30%$1.33$1.251.47 million shs$1.26 billion04/09/2024$1.36$1.37+0.74%$1.41$1.35718,135 shs$1.36 billion04/08/2024$1.37$1.36-0.73%$1.40$1.331.02 million shs$1.35 billion04/05/2024$1.35$1.37+1.48%$1.42$1.321.21 million shs$1.36 billion04/04/2024$1.38$1.35-2.17%$1.45$1.35777,340 shs$1.34 billion04/03/2024$1.40$1.38-1.43%$1.42$1.351.64 million shs$1.37 billion04/02/2024$1.47$1.40-4.76%$1.46$1.361.11 million shs$1.39 billion04/01/2024$1.58$1.47-6.96%$1.55$1.451.33 million shs$1.46 billion03/29/2024$1.58$1.58$1.65$1.531.07 million shs$1.57 billion03/28/2024$1.58$1.58$1.65$1.531.07 million shs$1.57 billion03/27/2024$1.52$1.58+3.95%$1.63$1.471.18 million shs$1.57 billion03/26/2024$1.44$1.52+5.56%$1.57$1.381.19 million shs$1.51 billion03/25/2024$1.44$1.44$1.56$1.421.18 million shs$1.43 billion03/22/2024$1.34$1.44+7.46%$1.48$1.321.67 million shs$1.43 billion03/21/2024$1.33$1.34+0.75%$1.40$1.291.15 million shs$1.33 billion03/20/2024$1.41$1.33-5.67%$1.44$1.243.08 million shs$1.32 billion03/19/2024$1.47$1.41-4.08%$1.52$1.381.18 million shs$1.40 billion03/18/2024$1.48$1.47-0.68%$1.51$1.371.09 million shs$1.46 billion03/15/2024$1.46$1.48+1.37%$1.49$1.42633,191 shs$1.47 billion03/14/2024$1.59$1.46-8.18%$1.56$1.411.34 million shs$1.45 billion03/13/2024$1.49$1.59+6.71%$1.70$1.481.40 million shs$1.58 billion03/12/2024$1.54$1.49-3.25%$1.55$1.421.62 million shs$1.48 billionWatch this FREE trading tutorial while it’s still available (Ad)On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details.03/11/2024$1.75$1.54-12.00%$1.80$1.522.09 million shs$1.53 billion03/08/2024$1.74$1.75+0.57%$2.05$1.7212.00 million shs$1.74 billion03/07/2024$1.71$1.74+1.75%$1.85$1.622.53 million shs$1.73 billion03/06/2024$1.46$1.71+17.12%$1.75$1.492.21 million shs$1.70 billion03/05/2024$1.48$1.46-1.35%$1.53$1.38815,506 shs$1.45 billion03/04/2024$1.59$1.48-6.92%$1.64$1.421.12 million shs$1.47 billion03/01/2024$1.57$1.59+1.27%$1.64$1.55923,339 shs$1.58 billion02/29/2024$1.61$1.57-2.48%$1.61$1.501.53 million shs$1.56 billion02/28/2024$1.71$1.61-5.85%$1.77$1.501.71 million shs$1.60 billion02/27/2024$1.64$1.71+4.27%$1.79$1.602.21 million shs$1.70 billion02/26/2024$1.48$1.64+10.81%$1.64$1.431.66 million shs$1.63 billion02/23/2024$1.38$1.48+7.25%$1.50$1.38807,972 shs$1.47 billion02/22/2024$1.50$1.38-8.00%$1.64$1.381.98 million shs$1.37 billion02/21/2024$1.26$1.50+19.05%$1.57$1.232.82 million shs$1.49 billion02/20/2024$1.20$1.26+5.00%$1.32$1.181.09 million shs$1.25 billion02/19/2024$1.20$1.20$1.28$1.18786,500 shs$1.19 billion02/16/2024$1.25$1.20-4.00%$1.28$1.18786,588 shs$1.19 billion02/15/2024$1.28$1.25-2.34%$1.32$1.22694,962 shs$1.24 billion02/14/2024$1.20$1.28+7.11%$1.32$1.20734,128 shs$1.27 billion02/13/2024$1.21$1.20-1.24%$1.29$1.151.06 million shs$1.19 billion02/12/2024$1.25$1.21-3.20%$1.28$1.191.09 million shs$1.20 billion02/09/2024$1.15$1.25+8.70%$1.33$1.191.49 million shs$1.24 billion02/08/2024$1.24$1.15-7.26%$1.27$1.121.57 million shs$1.14 billion02/07/2024$1.33$1.24-6.77%$1.42$1.202.15 million shs$1.23 billion02/06/2024$1.17$1.33+13.68%$1.38$1.133.01 million shs$1.32 billion Related Companies: BDTX Stock Price Chart AVXL Stock Price Chart MGTX Stock Price Chart GLUE Stock Price Chart IVVD Stock Price Chart MGX Stock Price Chart CRBU Stock Price Chart PGEN Stock Price Chart SOPH Stock Price Chart AGEN Stock Price Chart Receive ADAP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ADAP) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptimmune Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.